Skip to content
MedsAcross

Medicine

ParaGard T 380A 313.4 mg intrauterine system

Copper · Intrauterine · CooperSurgical
Available on requestPrescription onlyUS FDA

ParaGard T 380A 313.4 mg intrauterine system is a prescription medicine containing Copper for intrauterine use, marketed by CooperSurgical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at controlled room temperature: 59° to 86°F (15° to 30°C).

Key facts

Active ingredient (INN)
Copper
Brand
ParaGard T 380A
Strength
313.4 mg
Dosage form
Intrauterine system
Route
Intrauterine
Packs
1 pouch
Marketing authorisation holder
CooperSurgical
Manufacturer
CooperSurgical
Origin register
US FDA, United States
Storage
Store at controlled room temperature: 59° to 86°F (15° to 30°C).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
2 November 2017
Identifiers
RxCUI 2267305, 2267310DailyMed set ID 5ea7ce51-b87a-485e-b841-99466a07a4b2, 3c420b53-c95e-46af-aebd-73741be58391NDC 59365-5128, 59365-5129Application NDA018680

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 pouch in 1 carton / 1 intrauterine device in 1 pouch59365-5128-1CooperSurgical2 November 2017
1 pouch in 1 carton / 1 intrauterine device in 1 pouch59365-5129-1CooperSurgical15 August 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 November 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Copper

Clinical summary

Copper is a copper-containing intrauterine device indicated for prevention of pregnancy in females of reproductive potential for up to 10 years. It is available as intrauterine systems. MedsAcross supplies Copper for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Copper

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need ParaGard T 380A 313.4 mg intrauterine system for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.